Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cliff Perlis, MD
Fox Chase Cancer Center, Rockledge, PA
Principal Investigator - Jennifer Temel, MD
Massachusetts General Hospital
Principal Investigator - Madeline Duvic, MD
MD Anderson Cancer Center, Houston, TX
Principal Investigator - Maria Colavincenzo, MD
Robert H. Lurie Cancer Center, Northwestern University
Principal Investigator - Milan Anadkat, MD
Washington University School of Medicine
Principal Investigator - Serena Mraz, MD
Solano Clinical Research
Principal Investigator - Vera Hirsh, MD
McGill University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcgill University
Montreal, Quebec, Canada
- Solano Clinical Research
Vallejo, California, United States
- Robert H. Lurie Cancer Center, Northwestern University
Chicago, Illinois, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Fox Chase Cancer Center
Rockledge, Pennsylvania, United States
- the University of Texas, Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Apr 2008
- Primary completion
- 30 Dec 2009
- Completion
- 30 Dec 2009
- Last update posted
- 13 Nov 2020
- Registered enrollment
- 18
- Registry id
- NCT00656786
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.